Treatment of prostate cancer is often confusing for patients, but ProstaVysion? - the first personalized genetic panel for prostate cancer - optimizes that choice by defining the aggressiveness of the cancer. Exclusively from Bostwick Laboratories� and available immediately, ProstaVysionTM examines the genetic status of that patient's prostate cancer. This personalized analysis gives the patient and his physician the genetic information needed to make the best treatment decision...
No comments:
Post a Comment